Family history of prostate cancer should include second- and third-degree relatives
the ONA take:
According to a new study published in the journal The Prostate, researchers from Huntsman Cancer Institute at the University of Utah in Salt Lake City, Utah, have found that looking at a man's second- and third-degree relatives may be as significant as looking at his first-degree relatives to determine his risk for developing prostate cancer.
Typically, a physician will ask a patient about family members with prostate cancer, and that patient may indicate whether it is a first-degree relative, but researchers wanted to know if second- and third-degree relatives were equally as important to estimate prostate cancer risk for men based on prostate cancer family history. The researchers analyzed data from the Utah Population Database to estimate cancer risk for more than 7.3 million people based on family history.
Results showed that 10% of patients had three times the risk and 26% had two times the risk compared with men with no first-, second-, or third-degree relatives with prostate cancer.
The researchers plan to further investigate the effect of having both a maternal and paternal family history of prostate cancer, as well as other factors, to better calculate cancer risk.
The team is also investigating family history risk assessments for breast and lung cancers. Knowing a patient's family history, and therefore risk for developing cancer, will better determine which patients should receive further screening.
A man's second- and third-degree relatives may be as significant as looking at his first-degree relatives to determine his risk for developing prostate cancer.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- Screening Recommendations for Children with Common Cancer Predisposition Syndromes
- Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Lack of Transfusion Services a Barrier to Hospice Care for Patients With Blood Cancers
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
- Study Questions Safety of E-cigarettes vs Regular Tobacco Cigarettes
- Changes in Pulmonary Function Tests in Breast Carcinoma Patients Treated With Locoregional Post-mastectomy Radiotherapy: Results of a Pilot Study
- Increases in Liver Cancer Incidence Influenced by Higher Rates of Comorbidities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|